First Page | Document Content | |
---|---|---|
![]() Date: 2015-09-08 10:09:32Patent law Business Patent Acorda Therapeutics Kyle Bass Biotechnology Chemical patent Economy Biogen | Add to Reading List |
![]() | Trustee Lynn Schenk Lynn Schenk is an attorney and consultant in private practice with extensive public policy and business experience. She serves on the Board of Directors for Sempra Energy, Biogen Idec, the Scripps ReDocID: 1tNv2 - View Document |
![]() | The Institutional Embeddedness of High-Tech Regions: Relational Foundations of the Boston Biotechnology CommunityDocID: 1rqeK - View Document |
![]() | Management Insight Management Insight -Septrd 3.qxp_Layout:10 AM Page 1 Patently DisruptiveDocID: 1qXNa - View Document |
![]() | May 20, Novartis Makes Changes to Pharmaceutical Division Novartis has announced changes to its Pharmaceuticals Division by creating two business units: Novartis Pharmaceuticals and Novartis OnDocID: 1pLhY - View Document |
![]() | 20141009_Karte_Schweiz_GZA_DocID: 1pHFh - View Document |